Key result
In vitro, genuine NO donors show excellent correlation between sGC activation and NO release rates, whereas nitroglycerin acts as a partial agonist and may activate sGC via an NO-independent mechanism.
Nitroglycerin activates soluble guanylyl cyclase via an NO-independent mechanism and acts as a partial agonist compared to genuine NO donors.
Answers are grounded in this paper and cite their sources.
Questions nitroglycerin’s NO-dependent sGC activation; leaves open clinical relevance to tolerance or efficacy.
Nitric oxide (NO) performs a central role in biological systems, binding to the heme site of soluble guanylyl cyclase (sGC), leading to enzyme activation and elevation of intracellular levels of cGMP. Organic nitrates, in particular, nitroglycerin (GTN), are clinically important nitrovasodilators that function as NO-mimetics in biological systems. Comparison of sGC activation data with electrochemically measured rates of NO release for genuine NO donors, NONOates and nitrosothiols, yields an excellent correlation between the EC(50) for sGC activation and the rate constant for NO release, k(NO). However, activation of sGC by GTN and the nitrates has very different characteristics, including the requirement for specific added thiols, for example, cysteine. The reaction of GTN with cysteine in anaerobic solution yields NO slowly, and NO release, measured by chemiluminescence detection, is quenched by added metal ion chelator. The generation of NO under aerobic conditions is 100-fold slower than the anaerobic reaction. Furthermore, NO release from the reaction of GTN with cysteine in phosphate buffer is too slow to account for sGC activation by GTN/cysteine. The slow rate of the chemical reaction to release NO suggests that nitrates can activate sGC by an NO-independent mechanism. In contrast to the genuine NO donors, GTN behaves as a partial agonist with respect to sGC activation, but in the presence of the allosteric sGC activator, YC-1, GTN exhibits full agonist activity.
No takes yet. Share an insight, caveat, or question.
Artz et al. (2001) studied this question. NO donors and NO mimetics (GTN) was evaluated on sGC activation and NO release. In vitro, genuine NO donors show excellent correlation between sGC activation and NO release rates, whereas nitroglycerin acts as a partial agonist and may activate sGC via an NO-independent mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: